April 7, 2014 | Five former portfolio companies from the RAD BioMed accelerator have raised a total of $7 million in follow-on investments from the RAD Group and additional private investors. “Globes” reports that The companies are VGS Ltd., which has developed a method for reducing rejection of vein grafts; Vectorious Medical Technologies Ltd., which has developed an implant for early diagnosis of heart failure; Laminate Medical Technologies Ltd., which is developing an implant for improving renal vascular procedures; Perflow Medical Ltd., which is developing endovascular device for removing blood clots during brain surgery to prevent ischemic stroke; and Moebius Medical Ltd., which has developed liposomal lubricants for treating osteoarthritis.
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors

Ashdod Port Investing In Startups As Part Of Innovation Strategy

Facebook comments